• Skip to content
  • Rutgers.edu
  • RBHS
  • New Brunswick
  • Newark
  • Camden
  • Rutgers Health
  • Online
  • ResearchwithNJ.com
  • Facebook
  • Twitter
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Cores
  • Community
    • Our Services
    • Core Leadership & Advisory Council
    • Volunteering for a Clinical Trial FAQs
    • How to Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities & Publications
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Machine Learning
    • Biomarkers
    • COVID-19
    • ResearchMatch (RM)
    • Additional Resources
  • Education & Training
    • Workforce Development
    • Seminars, Workshops, Media Library
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Clinical and Translational Science Masters and Certificate Programs
    • Enhancing Diversity
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • KL2 & TL1
    • KL2 Mentored Career Development Awards
    • TL1 Predoctoral/Postdoctoral Training Awards
  • Clinical Trials Office
    • Clinical Research Units
    • ClinCard
    • DEEP6
    • OnCore
    • eREG
    • Clinical Research Investigator Registry
    • Part 11 – Electronic Signatures & Documents
    • Clinical Research SOPs
  • Contact Us
    • NJ ACTS Newsletter
Select Page

Home / News / A Round Table Discussion on COVID-19

A Round Table Discussion on COVID-19

by William Jester | Dec 10, 2020 | Community, Covid, News

A Round Table Discussion on COVID-19

Rutgers Biomedical and Health Sciences leaders Brian Strom, Vicente Gracias, Mary O’Dowd and Frank Ghinassi offer an update on the pandemic and efforts to keep the community safe and well. To view the round table discussion.

Recent Posts

  • New NJACTS Publication
  • NJACTS Community Engagement Core COVID-19 Resources
  • People Living with HIV Need Tailored COVID-19 Vaccination Information.
  • How the Pandemic Limited Access to Opioid Addiction Treatment for Racial and Ethnic Minority Groups.
  • Parental Depression Screening Beyond the Postpartum Period has the Potential to Identify Families Needing Support.

Archives

  • 2022
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (1,304)
  • Covid (867)
  • News (1,649)
  • Pilots (16)
Rutgers logo

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)
Contact RU – info at 732-445-info(4636)


  • Facebook

  • Twitter

  • YouTube

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.